Global Cancer Therapeutics Market worth USD 100.67 billion in 2016 and expected to reach USD 170.63 billion by 2022, at a CAGR of 9.2% from 2016 to 2022.

The objective of this report is to describe the market trends and revenue forecasts for the cancer therapeutics market for the next five years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the cancer therapeutics market. The scope of this report covers the cancer therapeutics market by its major segments, which include the types, therapies, and the major geographic regions.

KEY BENEFITS OF THE REPORT:
In-depth analysis of the key factors propelling the growth of the global market
Detailed analysis of the geographic region that will witness the strongest growth
Granular analysis of the current market scenario and the expected market growth
KEY PREMIUM INDUSTRY INSIGHTS:
The increasing prevalence of cancer, rising popularity of biologics, patent expirations of the popular drugs, and the rising impact of biosimilars are the key factors fuelling the growth of the cancer therapeutics market.
The key initiatives taken by the European Union (EU) and the United States Food and Drug Administration (US FDA) to provide pre-market approvals for the promising cancer therapies are fuelling the market for the cancer therapy.
However, the factors such as huge research & development cost, the threat of failure, adverse effects of cancer therapy, and stringent regulatory are the major restraints for the cancer therapeutics market.
MARKET SEGMENTATION:
This report analyzes the cancer therapeutics market by the following segments:

Cancer Therapeutics Market, by Types
Prostate Cancer
Blood Cancer
Lung Cancer
Skin Cancer
Gastric Cancer
Breast Cancer
Other Cancer Types
Cancer Therapeutics Market, by Therapy
Chemotherapy
Hormonal Therapy
Immunotherapy
Targeted Therapy
Other Therapies
KEY MARKET PLAYERS:
Key players in the cancer therapeutics market include:

F. Hoffmann-La Roche
Sanofi SA
GlaxoSmithKline plc
Johnson & Johnson Services, Inc.
Amgen Inc.
Merck & Co., Inc.
Pfizer Inc.
Novartis AG
Eli Lilly and Company
Celgene Corporation